Lipid nanoparticle loaded with Olig2 messenger RNA (Ribonucleic Acid) and application of lipid nanoparticle
A lipid nanoparticle and messenger technology, applied in nanotechnology, nanotechnology, nanomedicine, etc., can solve problems such as insufficient differentiation, and achieve the effect of promoting remyelination, targeting and effectiveness, and promoting differentiation and maturation.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Preparation and Characterization of Cationic Lipid Nanoparticles Loaded with Olig2 mRNA Targeting Antibody Modification.
[0054] 1. Preparation of LNPs modified with Olig2 mRNA targeting antibody.
[0055] preparation process such as figure 1 shown.
[0056] (1) With reference to the patent of application No. 202110566034.7, a plasmid expressing mouse Olig2 was constructed, and Olig2 mRNA was transcribed in vitro to synthesize Olig2 mRNA. The sequence of the Olig2-loaded messenger RNA is shown in SEQ ID NO: 1.
[0057] (2) The lipid phase DLink-MC3-DMA: DSPC: cholesterol: DMG-PEG2000 (molar ratio of 55:5:38.5:1.5) was dissolved in 90% ethanol; Volume ratio = 3:1; citric acid adjusted pH = 4), in which the molar ratio of loaded Olig2 messenger RNA and DLink-MC3-DMA is 1:10, which is injected and mixed by Nano Assemblr Benchtop microfluidic device to form nanometers of about 100 nm. Particle solution; then use a 3000 molecular weight dialysis bag to dialyze against DE...
Embodiment 2
[0070] The effect of LNPs modified with Olig2 mRNA targeting antibody on the uptake of mouse neural stem cell-derived OPCs in vitro was verified.
[0071] In order to explore the transfection effect of different concentrations of Olig2 mRNA / LNPs, OPCs were 5×10 per well. 5 seeded in 12-well plates. Use 1, 2, 4, 6 and 8 μg mL the next day -1 A final concentration of 5-carboxyfluorescein FAM-labeled C-Olig2 was incubated with OPCs for 6 h. Uptake efficiency was measured by flow cytometry. The result is as Figure 5 As shown in A-B, it can be seen that 6μg mL -1 C-Olig2 can achieve over 92% transfection effect.
Embodiment 3
[0073] The OPCs uptake effect of LNPs modified with Olig2 mRNA targeting antibody was verified in mice.
[0074] In order to investigate the intracranial injection of Olig2 mRNA / LNPs into mouse brain, in CD140a + Targeted expression levels in OPCs cells, mice received intracranial injection of C-Olig2 (0.05 mg / kg). After 24 hours, the mice were sacrificed, and the CD140a of the brain tissue was isolated + , CD140a - OPCs ( Image 6 ). The expression of Olig2 protein was detected by Western Blot, and the results were as follows Figure 7 shown, C-Olig2 successfully targets CD140a in the mouse brain + OPC, and overexpressed Olig2 protein.
[0075] The specific operations are as follows:
[0076] 1. Middle cerebral artery occlusion (MCAO) model mice received (0.05 mg kg -1 ) C-Olig2 was injected intracranially, and 24 hours later, the mouse brains were removed. Using Adult Brain Dissociation Reagent, after dissociation, red blood cells and cell debris are removed to make...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com